The Immune checkpoint inhibitor market refers to the market for drugs that block checkpoint proteins on T cells, allowing the immune system to better recognize and attack cancer cells. These drugs have been a major breakthrough in cancer treatment, with many patients experiencing long-term remission from previously untreatable cancers. The market includes a variety of drugs targeting …
Continue reading “Immune Checkpoint Inhibitor Market to Grow USD 155.1 billion by 2031 | 16.1% CAGR”